NCT03889509 A Systematic Review of Factors Associated With Pulmonary Arterial Hypertension in Systemic Sclerosis Status COMPLETED Phase N/A
NCT03844061 Belimumab and Rituximab Combination Therapy for the Treatment of Diffuse Cutaneous Systemic Sclerosis Status RECRUITING Phase PHASE2
NCT03819777 Volatile Organic Compounds (VOCs) as a Biomarker in Immune-mediated Pulmonary Arterial Hypertension (PAH) Status UNKNOWN Phase N/A
NCT03817424 A Study to Evaluate VIB7734 in Participants With Systemic Lupus Erythematosus (SLE), Cutaneous Lupus Erythematosus (CLE), Sjogren's Syndrome, Systemic Sclerosis, Polymyositis, and Dermatomyositis Status COMPLETED Phase PHASE1
NCT03798366 A Clinical Study to Test How Effective and Safe GLPG1690 is for Participants With Systemic Sclerosis Status COMPLETED Phase PHASE2
NCT03692299 Effectiveness of Saccharomyces Boulardii for Gastrointestinal Bacterial-overgrowth in Systemic Sclerosis Status COMPLETED Phase PHASE4
NCT03630211 Autologous Stem Cell Transplantation in Patients With Systemic Sclerosis Status RECRUITING Phase PHASE2
NCT03614208 Individualized Home-based Exercise Program for Patient With Systemic Sclerosis. Status COMPLETED Phase NA
NCT03582800 Subcutaneous Injection of Sodium Thiosulfate for Ectopic Calcifications or Ossifications. A Pilot Study Status RECRUITING Phase PHASE2
NCT03561233 Prevalence and Predictors of Proton Pump Inhibitor Partial Response in Gastroesophageal Reflux Disease in Systemic Sclerosis Status COMPLETED Phase PHASE1
NCT03558854 Evaluation of Effectiveness of Acetylsalicylic Acid on Markers of Vascular Dysfunction in Scleroderma Patients Status COMPLETED Phase PHASE4
NCT03543956 Professional and Personal Toxic Exposure in Systemic Sclerosis : Type, Intensity and Probability of Exposition Status COMPLETED Phase N/A